Apex Part 1: Updated Assessment of Bezuclastinib (CGT9486), a Selective KIT D816V Tyrosine Kinase Inhibitor, in Patients with Advanced Systemic Mastocytosis (Advsm) Daniel J. DeAngelo , Jason Gotlib , Vinod Pullarkat , Pankit Vachhani , Tsewang Tashi , Stephanie Lee , Gary J. Schiller , Anthony M. Hunter , Miguel Piris-Villaespesa , Helena Pomares , Bulai Livideanu Cridtina , Khalid Shoumariyeh , Jonathan Lambert , Tracy I. George , Jay Patel , Cristina Papayannidis , Tania Jain , Michael W. Deininger , Andreas Reiter , Gabriela S. Hobbs , Lei Sun , Deepak Nagendra , Jenna Zhang , Amanda Pilla , Kim Dishman , Marcus Carden , Deepti H. Radia Blood（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
